NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Alkem Laboratories has launched India's first semaglutide single-shot pre-filled syringes at a disruptive starting price of INR 350. This strategic expansion follows the company's March 2026 launch of injection pens and aims to lower entry barriers for patients managing Type 2 diabetes and obesity.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
